Full-Time
Board Certified Behavior Analyst Clinical Supervisor
Youth ABA, Behavior Clinic
Posted on 10/31/2025
BrightSpring Health Services
10,001+ employees
Home-based and community health services, pharmacy
Compensation Overview
$75k/yr
San Antonio, TX, USA
Hybrid
Hybrid role; in-person assessments required in San Antonio, TX.
 Medical, Clinical & Veterinary (3) |
|---|
| , , |
- BCBA license in the State of Texas (fully licensed BCBA in TX)
- Master's or Doctorate degree in human-related field that meets or exceeds state funding source specific requirements
- Independently licensed or certified
- Three or more years' experience working with individuals with developmental disabilities and/or ASD
- Assessment, evaluation, training and education, program planning, support services and clinical services to consumers, families and staff.
- Provides behavioral evaluations, acts as a liaison for psychiatric supports, participants in on-going assessments, develops and monitors behavioral intervention plans, meets with clients and their families, responds to emergencies, prepares and submits written reports regularly, maintains caseload files, and participates as a member of the multi-disciplinary and professional teams. Provide staff/family training on implemented programs.
- Review all Functional Behavior Assessments/Behavior Support Plans prior to implementation.
- Conduct home/community visits and consumer supervision as needed
- Ensure all FBAs and behavior support plans are current and contain appropriate measurable goals
- Sit on Interdisciplinary Team Meetings and psychiatric appointments as needed
- Maintain billable hours spreadsheet
- Ensure that all staff are maximizing productivity for each given client
- Conduct weekly meetings with BCBA: Review billable hours spreadsheets and discuss productivity; Review Weekly scheduling of technicians; Discuss cases on caseload; Review supervision session notes; Track and ensure 5% supervision is met; Review goal progress for each child; Identify key milestones regarding each case (reassessment dates, insurance requirements, etc.)
- Create and maintain satisfaction surveys in order to identify key performance indicators that may need improvement
- Create and conduct in-services focused on key performance indicators that need improvement
- Monitor, track and maintain all required certification documentation for each staff member according to job duties; BCBAs recertification date and supervision training; RBTs renewal dates (if applicable)
- Provide support for BCBAs with regards to scheduling coverage to ensure productivity is being met
- Stay current with all updates to State and Federal Regulations regarding services provided; In-service behavior clinician(s) on all changes made to regulations.
- Review all billing for BCBAs, BCaBA's, RBTs and Behavior Technicians on a minimum the 15th and last day of each month; Ensure all notes are uploaded with correct supporting documentation; Ensure that all notes are finalized with the correct time; Ensure each client is within appropriate utilization
- Participate in community activities statewide that will lead to company growth, including but not limited to: Meet with potential consumers and families; Attend community functions that are geared for potential recruitment and program development; Meet with school districts to provide current information on Spring Health Behavioral Health and Integrated Care Services; Explore other funding sources, ex: Early Intervention, Department of Education Services, etc.
- Other duties as assigned by State Director
BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Louisville, Kentucky
Founded
1974
Simplify's Take
What believers are saying
- Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
- Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
- Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.
What critics are saying
- Money Message ransomware stole 2M records including SSNs in March 2023 breach.
- DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
- Pomerantz investigates securities fraud by BrightSpring officers as of 2026.
What makes BrightSpring Health Services unique
- BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
- PharMerica dispenses 40 million prescriptions annually to 4 million patients.
- Provider services target intellectual disabilities via home-based behavioral health.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.
BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.
BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.
BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.
BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.